Papiller Benzeri Nükleer Özellikler Gösteren Noninvaziv Foliküler Tiroid Neoplazilerinde Eşlik Eden Papiller Tiroid Karsinomu için Preoperatif Öngördürücü Faktörler

MUHAMMET KOCABAŞ, YUSUF ÖZTÜRK

  • MUHAMMET KOCABAŞ: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  • YUSUF ÖZTÜRK: Sakarya University, Faculty of Medicine
  • Year : 2026
  • Vol : 42
  • Issue : 1
  •  Page : 50-57
Amaç: Papiller benzeri nükleer özellikler gösteren noninvaziv foliküler tiroid neoplazisi (NIFTP) olgularının klinik, ultrasonografik ve sitolojik özelliklerini değerlendirmek
ve papiller tiroid karsinomunun (PTK) eşlik etmesi ile ilişkili preoperatif faktörleri belirlemek.
Gereç ve Yöntemler: Bu retrospektif çalışmaya tiroidektomi sonrası histopatolojik olarak NIFTP tanısı konulan 115 hasta dâhil edildi. Demografik, ultrasonografik,
sitolojik ve patolojik veriler analiz edildi. Nodüller, Avrupa Tiroid Görüntüleme Raporlama ve Veri Sistemi (EU-TIRADS) ve Bethesda sitoloji sınıflamasına göre
değerlendirildi. Hastalar “PTK eşlik eden NIFTP” ve “PTK eşlik etmeyen NIFTP” olarak iki gruba ayrıldı. Eşzamanlı PTK’yi öngördüren faktörleri belirlemek için
karşılaştırmalı ve lojistik regresyon analizleri yapıldı.
Bulgular: Hastaların ortalama yaşı 46.78±13.98 yıl olup %74.8’i kadındı. NIFTP nodüllerinin ortalama boyutu 23.15±16.70 mm idi. EU-TIRADS sınıflamasına göre
nodüllerin %44.3’ü kategori 3, %14.8’i kategori 4 ve %37.4’ü kategori 5 olarak değerlendirildi. Sitoloji sonuçları en sık Bethesda I (%27.0), II (%32.2) ve III (%24.3) olarakraporlandı. Otuz üç hastada (%28,7) eşzamanlı PTK saptandı. Tek değişkenli analizde küçük nodül boyutu (OR 0.956, %95 GA 0.924–0.990, p=0.010) eşlik eden PTK ile anlamlı şekilde ilişkili bulunurken, EU-TIRADS kategori 5 (OR 2.288, 95% GA 1.002-5.228, p=0.050) sınırda anlamlılık gösterdi. Çok değişkenli analizde ise yalnızca küçük
nodül boyutu bağımsız bir öngördürücü olarak kaldı (OR 0.951, 95% GA 0.909-0.995, p=0.030).
Sonuç: NIFTP olgularında, daha küçük nodül boyutu eşlik eden PTK’nin bağımsız bir öngördürücüsü olarak saptanırken; solid kompozisyon, halo varlığı veya yüksek
EU-TIRADS skorları gibi şüpheli sonografik özellikler ise bağımsız öngördürücüler olarak bulunmadı. Küçük nodüllerin dikkatli değerlendirilmesi, preoperatif risk
sınıflandırmasının geliştirilmesine ve cerrahi karar sürecinin yönlendirilmesine katkı sağlayabilir.
Cite this Article As : Kocabas M, Ozturk Y. Preoperative Predictors of Coexistent Papillary Thyroid Carcinoma in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Selcuk Med J 2026;42(1): 50-57

Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File

Download Citation: BibTeX BibTeX File

Conflict of interest : The authors declare that they have no conflict of interest.
Selcuk Medical Journal
2026, Vol. 42 (1)
ISSN: 1017-6616
E-ISSN: 2149-8059
Received : , Accepted : , Published Online :

References

  1. 1. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016;2(8):1023-1029. doi:10.1001/jamaoncol.2016.0386
  2. 2. Rosario PW, Mourão GF. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a review for clinicians. Endocr Relat Cancer. 2019;26(5):R259-R266. doi:10.1530/ERC-19-0048
  3. 3. Nikiforov YE, Baloch ZW, Hodak SP, et al. Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features. JAMA Oncol. 2018;4(8):1125-1126. doi:10.1001/jamaoncol.2018.1446
  4. 4. Chin PD, Zhu CY, Sajed DP, et al. Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules. Endocr Pathol. 2020;31(4):377-384. doi:10.1007/s12022-020-09641-2
  5. 5. Lubitz C. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: What is in a name?. Cancer Cytopathol. 2018;126(11):895-896. doi:10.1002/cncy.22065
  6. 6. Faquin WC, Wong LQ, Afrogheh AH, et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol. 2016;124(3):181-187. doi:10.1002/cncy.21631
  7. 7. Bongiovanni M, Giovanella L, Romanelli F, Trimboli P. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis. Thyroid. 2019;29(2):222-228. doi:10.1089/thy.2018.0394
  8. 8. Hahn SY, Shin JH, Lim HK, et al. Preoperative differentiation between noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and non-NIFTP. Clin Endocrinol (Oxf). 2017;86(3):444-450. doi:10.1111/cen.13263
  9. 9. You SH, Lee KE, Yoo RE, et al. Prevention of total thyroidectomy in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) based on combined interpretation of ultrasonographic and cytopathologic results. Clin Endocrinol (Oxf). 2018;88(1):114-122. doi:10.1111/cen.13473
  10. 10. Seo JY, Park JH, Pyo JY, et al. A Multi-institutional Study of Prevalence and Clinicopathologic Features of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) in Korea. J Pathol Transl Med. 2019;53(6):378-385. doi:10.4132/jptm.2019.09.18
  11. 11. Vignali P, Proietti A, Macerola E, et al. Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center. Cancers (Basel). 2022;14(2):420. Published 2022 Jan 14. doi:10.3390/cancers14020420
  12. 12. Song SJ, LiVolsi VA, Montone K, Baloch Z. Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings. Cytopathology. 2017;28(6):488-494. doi:10.1111/cyt.12501
  13. 13. Canberk S, Montezuma D, Taştekin E, et al. "The other side of the coin": understanding noninvasive follicular tumor with papillary-like nuclear features in unifocal and multifocal settings. Hum Pathol. 2019;86:136-142. doi:10.1016/j.humpath.2018.10.040
  14. 14. Zajkowska K, Kopczyński J, Góźdź S, Kowalska A. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity. Endocr Connect. 2020;9(3):R47-R58. doi:10.1530/EC-19-0566
  15. 15. Juhlin CC, Mete O, Baloch ZW. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 2022;30(2):e220293. Published 2022 Dec 22. doi:10.1530/ERC-22-0293
  16. 16. Rossi ED, Faquin WC, Baloch Z, et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Update and Diagnostic Considerations-a Review. Endocr Pathol. 2019;30(2):155-162. doi:10.1007/s12022-019-9574-7
  17. 17. Muñoz I, Solórzano M, Fuentes I, et al. Noninvasive Follicular Thyroid Neoplasia With Papillary-Like Nuclear Characteristics (NIFTP): Clinico-Pathological Analysis in a Chilean Centre. Clin Endocrinol (Oxf). Published online August 24, 2025. doi:10.1111/cen.70026
  18. 18. Tazeoglu D, Dag A, Esmer AC, Benli S, Arslan B, Arpaci RB. Is it Possible to Diagnose "Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features" Preoperatively?. Indian J Surg Oncol. 2023;14(2):368-375. doi:10.1007/s13193-022-01696-3
  19. 19. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol. 2016;29(7):698-707. doi:10.1038/modpathol.2016.65
  20. 20. Yang GCH, Fried KO. Pathologic basis of the sonographic differences between thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Ultrasonography. 2018;37(2):157-163. doi:10.14366/usg.17045
  21. 21. Kwon MR, Shin JH, Hahn SY, et al. Histogram analysis of greyscale sonograms to differentiate between the subtypes of follicular variant of papillary thyroid cancer. Clin Radiol. 2018;73(6):591.e1-591.e7. doi:10.1016/j.crad.2017.12.008
  22. 22. Kholová I, Haaga E, Ludvik J, et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Tumour Entity with a Short History. A Review on Challenges in Our Microscopes, Molecular and Ultrasonographic Profile. Diagnostics (Basel). 2022;12(2):250. Published 2022 Jan 20. doi:10.3390/diagnostics12020250
  23. 23. Hekimsoy İ, Ertan Y, Serin G, et al. Comparison of ultrasound findings of papillary thyroid carcinoma subtypes based on the 2022 WHO classification of thyroid neoplasms. Front Endocrinol (Lausanne). 2024;15:1434787. Published 2024 Aug 14. doi:10.3389/fendo.2024.1434787
  24. 24. Liu R, Gao L, Xia Y, et al. Three ultrasound phenotypes of non-invasive follicular thyroid neoplasm with papillary-like nuclear features proposed for imaging-pathology analysis: single center experience. Gland Surg. 2021;10(1):307-318. doi:10.21037/gs-20-612
  25. 25. Leoncini A, Camponovo C, Gamarra E, et al. NIFTP-adjusted risk estimation of Bethesda thyroid cytology categories should consider the indication for FNA according to TIRADS. Endocrine. 2024;85(3):1261-1267. doi:10.1007/s12020-024-03800-9
  26. 26. Andrade de Almeida M, Canão P, Capela J, et al. Preoperative assessment of NIFTP clinicopathological characteristics and its impact on avoiding overtreatment. Langenbecks Arch Surg. 2025;410(1):204. Published 2025 Jul 1. doi:10.1007/s00423-025-03788-4
  27. 27. Canini V, Leni D, Pincelli AI, et al. Clinical-pathological issues in thyroid pathology: study on the routine application of NIFTP diagnostic criteria. Sci Rep. 2019;9(1):13179. Published 2019 Sep 12. doi:10.1038/s41598-019-49851-1
  28. 28. Fama F, Sindoni A, Cicciu M, et al. Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter. Arch Endocrinol Metab. 2018;62(2):139-148. Published 2018 Apr 5. doi:10.20945/2359-3997000000017
  29. 29. Eloy C, Russ G, Suciu V, et al. Preoperative diagnosis of thyroid nodules: An integrated multidisciplinary approach. Cancer Cytopathol. 2022;130(5):320-325. doi:10.1002/cncy.22546